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Purpose: Recently, laparoscopy-assisted gastrectomy (LAG) has been widely accepted modality for early gastric cancer in Korea. The in-
dication of LAG may be extended in an experienced institution. In our institution, the first case of laparoscopy-assisted gastrectomy (LAG) 
for gastric cancer was performed in May 1998. We retrospectively reviewed the long-term oncologic outcomes over 12 years to clarify 
the feasibility of LAG for gastric cancer.
Materials and Methods: The authors retrospectively analyzed 753 patients who underwent LAG for gastric cancer, from May 1998 to 
August 2010. We reviewed clinicopathological features, postoperative outcomes, mortality and morbidity, recurrence, and survival of 
LAG for gastric cancer.
Results: During the time period, 3,039 operations for gastric cancer were performed. Among them, 753 cases were done by LAG 
(24.8%). There were 69 cases of total gastrectomy, 682 subtotal gastrectomies, and 2 proximal gastrectomies. According to TNM stage, 
8 patients were in stage 0, 619 in stage I, 88 in stage II, and 38 in stage III. The operation-related complications occurred in 77 cases 
(10.2%). Median follow-up period was 56.2 months (range 0.7~165.6 months). Twenty-five patients (3.3%) developed recurrence, 
during the follow-up period. The overall 5-year and disease free survival rates were 97.1% and 96.3%, respectively. 
Conclusions: The number of postoperative complications and survival rates of our series were comparable to the results from that of 
other reports. The authors consider LAG to be a feasible alternative for the treatment of early gastric cancer. However, rationale for lapa-
roscopic surgery in advanced gastric cancer has yet to be determined.
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Introduction
Surgical resection for gastric cancer is the only therapeu-
tic modality for curability.(1) Laparoscopy-assisted gastrectomy 
(LAG) has been applied and increased significantly in the surgical 
management of gastric cancer in recent years. In Asian countries, 
such as Japan and Korea, it has become a standard therapy for 
early stage gastric cancer.(2,3) Several studies have demonstrated 
short-term postoperative advantages of LAG.(3-5) Kitano et al.(2) 
reported excellent long-term outcome of laparoscopic gastrec-
tomy in a retrospective multicenter study for early gastric cancer. 
Recently, there was first multicenter, prospective, randomized trial 
for laparoscopy-assisted distal gastrectomy to assess the short- and 
long-term outcomes for early gastric cancer in Korea (Korea Lapa-
roscopic Gastrointestinal Surgery Study Group [KLASS] trial).(6) 
In the near future, this trial will prove that laparoscopic surgery is 
feasible and acceptable procedure and will hopefully answer the 
concern of long term outcomes. Furthermore, improvements in in-
struments and laparoscopic technique have allowed for widespread 
acceptance of laparoscopic surgery, not only for distal gastrectomy 
but also for other gastrectomy.(7-9) As a results, study is needed to 12 Years’ Experience of LAG
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confirm that this procedure is oncologically feasible from a long-
term follow-up perspective.
Since 1998, 753 cases of LAG have been performed at our insti-
tution by two surgeons. Based on these data of our 12 year experi-
ence, we have reviewed the oncological outcomes for laparoscopy-
assisted gastrectomy, to determine its long-term effectiveness and 
patient survival. 
Materials and Methods
Between May 1998 and August 2010, 3,039 operations for 
gastric cancer were performed in our institute. Among them, 753 
patients underwent LAG by two experienced surgeons. W e assessed 
the depth of invasion preoperatively by means of endoscopy and 
endoscopic ultrasonography and assessed the presence or absence 
of lymph node metastases using computed tomography. In early 
periods, our indication of LAG for gastric cancer was cT1N0M0 
according to the 6th edition of the American Joint Committee on 
Cancer (AJCC) staging criteria.(10) In 2006, we extended the indi-
cation to T2N1M0. W e excluded the patients who were candidates 
for endoscopic submucosal dissection from this study.
Data obtained for each patient included the following: age, sex, 
body mass index (BMI), comorbidity disease, tumor size, histo-
logical type, tumor location, type of gastrectomy, reconstruction, 
resection margin, T stage, extent of lymph node dissection, N stage, 
postoperative outcomes, recurrences, survival, and gastric cancer 
stage classified according to the 7th edition of the AJCC staging 
criteria.(11) The classification of lymph node dissection was done 
according to 2010 Japanese gastric cancer treatment guidelines 
(ver.3).(12) All the values were expressed as means±standard de-
viations.
All patients were managed routinely using a standardized 
postoperative protocol as follows: (1) no nasogastric intubation or 
preoperative mechanical bowel preparation, (2) minimal spillage of 
gastric contents, (3) the use of one or two closed suction drains, (4) 
sips of water at 48 hours after the operation, (5) a clear liquid diet at 
three days after the operation, and (6) discharge at six or seven days 
after a soft diet with no abnormal clinical symptoms. In advanced 
gastric cancer cases with stages beyond stage II, they received six 
cycles of adjuvant chemotherapy with intravenous 5-fluorouracil 
and cisplatin.
Follow-up results were obtained from patient hospital records, 
and telephone calls, and recurrence was determined by endoscopy, 
computed tomography, and positron emission tomography. All the 
follow-up patients were monitored postoperatively by a routine 
check for blood tests, tumor marker (Alpha-Fetoprotein, carcino-
embryonic antigen, and carbohydrate antigen 19-9), chest radi-
ography, endoscopy, and computed tomography. In patients with 
early gastric cancer, follow-up studies were performed every six 
months for the second year and annually for the following years. 
For patients with advanced gastric cancer, studies were carried out 
every three months for the first year, every six months for next 
year, and annually for the next three years.
Statistical results of the clinicopathologic factors and postopera-
tive outcomes were analyzed using GraphPadInStat
® (version 3.06, 
GraphPad Software Inc., San Diego, CA, USA). Survival curves 
were calculated by the Kaplan-Meier method using SPSS version 
18.0 (SPSS Inc., Chicago, IL, USA).
1. Surgical procedure
All laparoscopy-assisted gastrectomies were performed accord-
ing to the standard procedure guidelines as follows. All patients 
were placed in lithotomy position under general anesthesia. The 
surgeon stood on the patient’s right, with the first assistant on the 
patient’s left and the camera assistant between the patient’s legs. 
Routinely, an umbilical trocar (11 mm) was inserted using the open 
method. A carbon dioxide pneumoperitoneum was created through 
the umbilical port, and the pressure was maintained between 12 
and 14 mmHg. A rigid (30 degree) laparoscope was then intro-
duced through the umbilical port. Under laparoscopic guidance, 
four trocars were introduced, consisting of bilateral subcostal (right 
side 5 mm, left side 11 mm) and bilateral mid-abdominal ports (right 
side 12 mm, left side 5 mm). First, the greater omentum wasdivided 
at the mid portion of the transverse colonabout 4~5 cm from the 
gastroepiploic arcade toward the lower pole of the spleen using 
Harmonic ACE (Ethicon Endo-Surgery, Cincinnati, OH, USA). 
Next, the right omentum and lymph nodes were dissected along 
the right gastroepiploic vessels (no. 4d). The infrapyloric nodes (no. 
6) and the nodes along the superior mesenteric vein (no. 14v) were 
dissected. After the suprapyloric nodes (no. 5) and the nodes along 
the proper hepatic artery (no. 12a) were dissected, the duodenum 
just distal to the pyloric ring was transected. Then the nodes along 
the common hepatic artery (no. 8a) and the proximal splenic artery 
(no. 11p) were dissected. After dissecting of the nodes along the 
left gastric artery (no. 7) and the nodes around the celiac artery 
(no. 9), dissection of the right cardial nodes (no. 1) and the nodes 
along the lesser curvature (no. 3) were performed. A 5-cm upper 
midline or transverse skin incision was made from the substernal Kim KH, et al.
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angle or right subcostal area, and an incision template (Alexis
TM 
W ound retractor, Applied Medical, Rancho Santa Margarita, CA, 
USA) was applied on the incision site. Billroth I gastroduodenos-
tomy was performed by a circular stapler (Proximate CDH 29; 
Ethicon Endo-Surgery), and Billroth II gastrojejunostomy us-
ing flexible laparoscopic stapling devices (Echelon Flex, Ethicon 
Endo-Surgery) was performed or a hand-sewing technique was 
adopted as used for conventional open surgery. In case of total 
gastrectomy, the short gastric vessels were divided from the lower 
pole to the upper pole of the spleen, and the lymph nodes along 
the short gastric vessels (no. 4sa) were dissected. Additionally, the 
lymph nodes along the distal splenic artery (no. 11d) and the left 
paracardial lymph nodes (no. 2) were dissected. Reconstruction of 
total gastrectomy was extracorporeally performed by Roux-en-Y 
anastomosis. After jejunojejunostomy, esophagojejunostomy was 
performed using a circular stapler (Proximate CDH 25; Ethicon 
Endo-Surgery).
Results
1. Patient characteristics
Since May 1998, laparoscopy-assisted gastrectomies have 
gradually increased in our institute (Fig. 1). The clinicopathological 
characteristics ofthe patients are presented in Table 1. The mean 
age was 58.4±12.7 years (range, 24~87 years). Among those 753 
patients who underwent laparoscopic surgeries, 462 were men 
(61.4%) and 291 were women (38.6%). The mean body mass index 
was 23.2±2.9 kg/m
2. The mean tumor size was 2.9±2.1 cm. The 
most common histologic type was poorly differentiated. Most of 
the tumor was located at the lower area of stomach. Subtotal gas-
trectomy and BillrothI anastomosis were the most common pro-
cedure. Proximal and distal margins of partial gastrectomy (Partial 
Fig. 1. Annual results of laparoscopy-assisted gastrectomy. LAG = 
laparoscopy-assisted gastrectomy.
Table 1. Clinicopathological features
Clinicopathological features LAG (n=753, %)
Age (yr)* 58.4±12.7
Gender
  Male
  Female
462 (61.4)
291 (38.6)
BMI (kg/m
2)* 23.2±2.9
Size of tumor (cm)* 2.9±2.1
Histologic type
  Well differentiated
  Moderately differentiated
  Poorly differentiated
  Signet ring cell
  Other
199 (26.4)
221 (29.4)
255 (33.9)
59 (7.8)
19 (2.5)
Tumor location
  Upper
  Middle
  Lower
  Diffuse
44 (5.8)
179 (23.8)
527 (70.0)
3 (0.4)
Type of gastrectomy
  Partial gastrectomy
†
    Subtotal
    Proximal
  Total gastrectomy
684 (90.8)
682
2
69 (9.2)
Reconstruction
  B-I
  B-II
  R-Y
  Esophagogastrostomy
496 (65.9)
181 (24.0)
74 (9.8)
2 (0.3)
Resection margin (cm)*
  Partial gastrectomy
    Proximal
    Distal
  Total
    Proximal
    Distal
4.8±2.8
5.6±3.0
3.6±3.5
12.1±4.8
Depth of invasion (T stage)
  Tis
  T1a
  T1b
  T2
  T3
  T4a
8 (1.1)
355 (47.1)
229 (30.4)
78 (10.4)
50 (6.6)
33 (4.4)12 Years’ Experience of LAG
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gastrectomy includes distal subtotal gastrectomy and proximal 
subtotal gastrectomy) were 4.8±2.8 and 5.6±3.0 cm and those of 
total gastrectomy were 3.6±3.5 and 12.1±4.8 cm, respectively. 
According to the TNM stages (AJCC 7th edition), stage 0 was 
found in 8 (1.1%) patients, I in 619 (82.2%) patients, II in 88 (11.7%), 
III in 38 (5.0%). Seven hundred and sixteen patients received over 
D2 dissection according to 2010 Japanese gastric cancer treatment 
guidelines (ver.3).(12) The mean number of retrieved lymph nodes 
of partial gastrectomy was 34.1±13.9 and that of total gastrectomy 
was 40.6±17.1, respectively (Table 1).
2. Postoperative outcomes 
For all 753 patients, the meanoperation time was 214.0±52.6 
min (range, 110~415 min; partial gastrectomy, 209.3±49.9 min; 
Table 1. Continuted
Clinicopathological features LAG (n=753, %)
TNM stage
†
  0
  I
  II
  III
8 (1.1)
619 (82.2)
88 (11.7)
38 (5.0)
Extent of lymph node dissection
  D1+
  ≥D2
37 (4.9)
716 (95.1)
Retrieved lymph node (number)*
Partial gastrectomy
  Total gastrectomy
34.7±14.3
34.1±13.9
40.6±17.1
*All values are the mean and standard deviation. 
†Partial gastrectomy 
includes distal subtotal gastrectomy and proximal subtotal gastrec-
tomy. LAG = laparoscopy-assisted gastrectomy.
Table 2. Postoperative outcomes
Postoperative outcomes
Operative times (min)*
  Partial gastrectomy
†
  Total gastrectomy
214.0±52.6
209.3±49.9
261.0±55.7
Hospital stay (d)* 8.4±8.0
First flatus time (d)* 2.9±0.9
Complication rate (%)
  Major (re-operation and death)
    Re-operation
    Death
  Minor 
11 (1.5%)
1 (0.1%)
65 (8.6%)
Median follow-up duration (mo, range) 56.2 (0.7~165.6)
*All values are the mean and standard deviation. 
†Partial gastrectomy 
includes distal subtotal gastrectomy and proximal subtotal gastrec-
tomy.
Table 3. Postoperative morbidity and mortality
Morbidity and mortality Number Treatment
Morbidity
  Major 
    Intra-abdominal bleeding
    Intra-abdominal abscess
    Duodenal stump leakage
    EJ leakage
    Gastroduodenostomy leakage
  Minor
    Wound problem
    Intra-abdominal abscess
    Intra-abdominal bleeding
    Intra-luminal bleeding
    Ileus
    Pancreatitis
    Pulmonary problems
    Urinary problems
    Renal problem
    Hepatic problem
    Cardiac problem
    Others
11 (1.5%)
1
1
6
1
2
65 (8.6%)
7
7
8
12
4
1
11
2
1
1
1
10
Re-operation
Conservative care
Mortality
  Multi-organ failure 1 (0.1%) Perioperative death
EJ = esophagojejunostomy.
Table 4. The sites of recurrence
Recurrence sites Number of patients recurred 
(n=25)
Lung only
Liver+lymph node
Liver only
Peritoneum only
Lymph node only
Ovary only
Remnant stomach only
Bone+lymph node 
Bone+peritoneum
Bone+liver
Ovary+peritoneum
Peritoneum+lymph node
3
4
3
3
3
2
2
1
1
1
1
1Kim KH, et al.
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total gastrectomy, 261.0±55.7 min). The mean postoperative hos-
pital stay and the length of time until the first flatus were 8.4±8.0 
days and 2.9±0.9 days, respectively (Table 2). There were 76 oper-
ation-related morbidities (10.1%) and one mortality (0.1%). Eleven 
major complications (intra-abdominal bleeding, one case; intra-
abdominal abscess, one case; duodenal stump leakage, six cases; 
esophagojejunostomy leakage, one case; gastroduodenostomy leak-
age, two cases) needed re-operation. Sixty-five patients with minor 
complications were treated with conservative care. One patient died 
from multi-organ failure after 28 postoperative days (Table 3).
3. Follow-up results
The median follow-up period was 56.2 months (range 0.7~165.6 
months). Tumor recurrence was detected in 25 patients (3.3%) 
during the follow-up period. The sites of recurrence are shown in 
Table 4. Twenty-five patients had a total of 34 specific sites of re-
currence. Hepatic and lymph node metastasis were the most com-
mon specific sites of recurrence. As for lymph node metastases, one 
patient was found at para-aortic area, 2 at extra-abdominal area, 1 
at peripancreatic area, 1 at pericholedochal area, and 1 at perigastric 
area.
The overall 5-year survival rate and disease free survival rate 
were 97.1% and 96.3%, respectively (Fig. 2). According to TNM 
stage, the overall 5-year and disease-free survival rates were 100% 
for 8 patients with stage 0 disease, 99.3% and 98.3% for 619 patients 
with stage I disease, 89.5% and 89.4% for 88 patients with stage II 
disease, 76.1% and 78.2% for 38 patients with stage III disease, re-
spectively (Fig. 3).
Fig. 2. Survival characteristics of patients. The overall 5 year survival rate (A) and disease free survival rate (B) of all 753 patients were 97.1% and 
96.3%, respectively.
Fig. 3. Comparison of overall 5-year survival rate (A) and disease free survival rate (B) according to TNM stage based on the 7th edition of the 
American Joint Committee on Cancer staging criteria. Overall 5-year and disease free survival rates of stage 0, I, II, and III were 100, 99.3, 89.5, and 
76.1% and 100, 98.3, 89.4, 80.2, and 78.2%, respectively.12 Years’ Experience of LAG
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Discussion
In recent years, laparoscopic techniques have gained worldwide 
clinical acceptance in surgical practice. In the case of colorectal 
cancer, laparoscopic surgery has been applied for locally advanced 
cancer.(13) Since laparoscopic-assisted distal gastrectomy for early 
gastric cancer (EGC) was first performed in 1991 and first reported 
in 1994,(14) this procedure for early gastric cancer has been adapt-
ed quickly. This approach offers important advantages when com-
pared with open surgery such as better cosmetic effect, improved 
quality of life, less intense pain, shortened hospital stay, early 
rehabilitation, and early return to social activity.(2-5,15) Improve-
ments in instruments and laparoscopic technique have allowed for 
widespread acceptance, not only for distal gastrectomy but also for 
other resections, such as proximal, total, and functional preserving 
gastrectomy.(7-9) Recently, some surgeons were concerned with 
laparoscopic surgery for advanced gastric cancer. Since Uyama et 
al.(16) reported laparoscopy-assisted total gastrectomy with D2 
lymph node dissection and distal pancreaticosplenectomy for ad-
vanced upper-third gastric cancer in 1999, there have been several 
studies to determine the technical feasibility of D2 lymph node 
dissection in AGC.(17,18) However, the application of laparoscopic 
surgery for advanced gastric cancer continues to be questionable 
because of the technical difficulty of lymphadenectomy and lack of 
data on the procedure’s oncologic adequacy.
The characteristics of early gastric cancer patients with lymph 
node metastases have been reported in many institutions, but the 
appropriate extent of lymph node dissection for early gastric cancer 
remains controversial.(19,20) Nevertheless, most gastric surgeons 
have thought that D1+β lymph node dissection was the standard 
and appropriate surgical procedure for patients with early gastric 
cancer.(21,22) Also, D2 lymph node dissection was considered to 
be optimal procedure for patients with advanced gastric cancer.
(23) Many reports about LAG for early gastric cancer showed that 
the number of retrieved lymph nodes was not different from that 
of retrieved lymph nodes during open surgery.(24,25) Also, we 
previously reported the same results.(3) In advanced gastric cancer, 
other authors showed that there was no statistical difference in the 
number of retrieved lymph nodes with D2 lymphadenectomy.(17,18) 
In the present study, we performed 37 cases with D1+, 716 with 
D2 or more lymph node dissection according to 2010 Japanese 
gastric cancer treatment guidelines (ver.3).(12) In our early periods 
of LAG, D1+ dissection was performed for early gastric cancer in 
part. After overcoming the learning curve of LAG, we performed 
with D2 for early gastric cancer and over D2 for advanced gastric 
cancer according to 2010 Japanese gastric cancer treatment guide-
lines (ver.3).(12)
Several studies presented mortality and morbidity associated 
with LAG. In the KLASS-I trial,(6) the authors reported 1.1% of 
mortality and 10.5% of morbidity. Other authors reported postop-
erative mortality ranges between 0% and 3%.(2-4,17,18,25) Re-
garding the reported postoperative morbidity, the range has been 
reported from 2% to 20% for patients who underwent laparoscopy-
assisted gastrectomy.(2-4,17,18,25) In the present study, there were 
one case (0.1%) of postoperative mortality and 76 cases (10.1%) of 
operation related morbidities. One death occurred because of multi-
organ failure after 28 postoperative days. He was preoperatively a 
very complicated patient. His underlying diseases were pneumonia, 
a trial fibrillation, right middle cerebral artery infarction, and hy-
pertension. He underwent laparoscopy-assisted distal gastrectomy 
(Billroth-I). After surgery, he was taken to the intensive care unit 
because of his condition. Unfortunately, his cardiac, pulmonary, 
and renal functions gradually failed.
To date, several authors have shown no difference in recur-
rence or survival following laparoscopic surgery and open surgery 
for early gastric cancer. However, in the case of advanced gastric 
cancer, the difference has remained controversial. Recently, Song et 
al.(26) reported on their multicenter retrospective analysis about re-
currence following LAG for gastric cancer. They stated that the in-
cidence of recurrence was 3.5% in all patients, 1.6% in early gastric 
cancer, and 13.4% in advanced gastric cancer. During our follow-
up period, we detected 25 patients (3.3%) with tumor recurrence. 
Incidence of recurrence was 1.4% (8/592) in early gastric cancer 
and 10.6% (17/161) in advanced gastric cancer. Tokunaga et al.(27) 
said that patients with clinically early but pathologically advanced 
gastric cancer had a better prognosis compared to patients with 
clinically and pathologically advanced gastric cancer. As a result, 
we could explain the lower rate of recurrence of advanced gastric 
cancer in our LAG cases because of the reason mentioned above.
In terms of the specific recurrence site, Song et al.(26) reported 
that the peritoneum and liver were the most common recurrence 
sites. Also, Lee and Kim(28) said that the peritoneum and liver 
were major sites of recurrence. In the present study, liver (8 sites), 
peritoneal metastasis (6 sites), and lymph node metastasis (9 sites) 
were the most common specific sites of recurrence. Some au-
thors reported their period of recurrence after operation. Song et 
al.(26) showed that recurrences mostly occurred within three years. 
Hwang et al.(29) reported that their recurrences occurred within 34 Kim KH, et al.
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months. In the same manner, most recurrences (21/25) in our study 
occurred within three years.
The prognosis of patients with early gastric cancer is known to 
be excellent, with 5-year survival rates of 90% or more. Fujiwara 
et al.(30) reported on the survival rates after five years of follow-
up for 94 patients with early gastric cancer. They showed that the 
overall 5-year survival rate was 90.0%, and the 5-year recurrence-
free survival rate was 95.6%. Kitano et al.(2) also reported on the 
long-term outcome of laparoscopic gastrectomy in a retrospective 
multicenter study on laparoscopic gastrectomy for early gastric can-
cer that analyzed 1,294 patients from 16 institutions. They reported 
that the 5-year disease-free survival rates were 99.8, 98.7, and 
85.7% for stages IA, IB, and II, respectively. In the case of laparo-
scopic surgery for advanced gastric cancer, some authors reported 
their short-term and long-term outcomes. Lee and Kim(28) pre-
sented the long-term outcome of the overall (81.4%) and disease 
free (72.4%) survival rates for advanced gastric cancer. Hwang et 
al.(29) reported that the disease-free actual 3-year survival rate 
was 79.2 for advanced gastric cancer. In our cases, we showed the 
5-year survival rates to be overall 5-year survival rates of stage 0, I, 
II, and III were 100, 99.3, 89.5 and 76.1%.
This study has drawbacks of no comparative analysis with open 
gastrectomy. For the elucidation of oncologic safety and clinical 
feasibility of laparoscopic assisted gastrectomy, comparative study 
of short term and long term results with open method will be nec-
essary.
Although further study is needed comparing LAG to open 
gastrectomy, we think that LAG with adequate lymph node dis-
section for early gastric cancer is an oncologically safe, feasible, 
and curative procedure. However, rationale for laparoscopic surgery 
in advanced gastric cancer has yet to be determined. Therefore, a 
large-scale multicenter randomized trial is needed to confirm the 
oncological safety and feasibility of LAG for patients with advanced 
gastric cancer.
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